Table of Contents
Description
Priority Announcements offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the Proof of Principle Phase I funding opportunity.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations. Should CIHR funding levels be decreased by Parliament, CIHR reserves the right to defer or suspend payments to grants received as a result of this funding opportunity.
Funds Available for Research in All Areas:
Funds are available for applications in all areas of research that address any important health problem or issue through the Proof of Principle Phase I funding opportunity.
Funds Available for Research in Specific Areas:
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
CIHR Research Priority Areas:
- Cancer Early Detection, Imaging, or Translational Therapeutics
- Drug Development
- Regional Partnerships Program – New Brunswick
- Regional Partnerships Program – Newfoundland and Labrador
Top
Objectives
CIHR Research Priority Areas:
1. Cancer Early Detection, Imaging, or Translational Therapeutics
Summary:
- The CIHR Institute of Cancer Research (CIHR-ICR), will fund applications that are determined to be relevant to the research priority areas described below:
- Early Detection of Cancer: this includes, but is not limited to:
- new or improved cancer screening technologies to detect early stage malignant or pre-malignant lesions
- molecular genetic tests for predicting cancer risk
- biomarker-based screening technologies
- new or improved cancer screening technologies that are safer, or offer increased sensitivity and specificity over current methods
- Cancer Imaging: this includes, but is not limited to:
- novel or improved imaging and spectroscopic technologies for early detection, screening, diagnosis and image-guided treatment of cancer
- Translational Therapeutics: the development of cancer therapeutics which includes, but is not limited to:
- small molecule therapeutics for validated cancer targets
- biologicals aimed against a validated cancer target or cancer cells
- devices for cancer therapy
- More information on the research priorities of CIHR-ICR can be found on its web sites.
Funds Available:
- The total amount available for this initiative is $ 480,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $ 160,000 per annum for up to one year.
Additional Information:
- This Priority Announcement will require the completion of Relevance Form.
- The grant must be held in Canada.
- The grant is non-renewable
- CIHR-ICR will NOT support projects involving high throughput screening or cancer target validation in the context of this specific funding opportunity.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
2. Drug Development
Summary:
- CIHR will fund applications in the area of drug development to facilitate the advancement of promising drug compounds discovered in academia to subsequent commercial and clinical development. Within the context of the Proof of Principle Phase I Program, CIHR will support applications focusing on:
- Target validation
- Lead compound validation
- Lead compound optimization
Funds Available:
- The total amount available for this initiative is $ 500,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is up to $160,000 for a maximum of 1 year.
- CIHR anticipates that three grants will be funded through this competition.
Additional Information:
- This Priority Announcement will not require the completion of Relevance Form.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
3. Regional Partnerships Program – New Brunswick
Summary
- CIHR, through the Regional Partnerships Program (RPP) to in partnership with New Brunswick-RPP is interested in funding applications in all four themes of health research that contribute to the goal of building health research capacity in New Brunswick which meet RPP eligibility. Information on the research priorities of New Brunswick can be found on their website.
Funds available
- The maximum amount awarded for a single grant is up to $160,000 for a maximum of 1 year.
- The Regional Partnerships Program provides funding for highly ranked applications within the fundable range that are not funded through the regular CIHR competition to which they were submitted. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information:
- This Priority Announcement will not require the completion of an additional Relevance Form;
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The grant must be held in New Brunswick and in accordance with the CIHR-RPP guidelines. For eligibility guidelines, see the New Brunswick and Canadian Institutes of Health Research Regional Partnership Program description;
- Funding is conditional upon the availability of funds;
- When applying through ResearchNet, please ensure to select "RPP-New Brunswick" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
4. Regional Partnerships Program – Newfoundland and Labrador
Summary
Funds Available
- The maximum amount awarded for a single grant is up to $160,000 for a maximum of 1 year.
- The Regional Partnerships Program provides funding for highly ranked applications within the fundable range that are not funded through the regular CIHR competition to which they were submitted. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- This Priority Announcement will not require the completion of an additional Relevance Form;
- Please note researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is the Office of Research and Graduate Studies (see contact information below);
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The grant must be held in NL and in accordance with the CIHR-RPP guidelines;
- Funding is conditional upon the availability of funds;
- When applying through ResearchNet, please ensure to select "RPP-Newfoundland and Labrador" in the drop-down menu of the priority announcement.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
Top
Eligibility
For Eligibility, Guidelines and Performance Measurement please refer to the Proof of Principle: Phase I (2009-2010) funding opportunity.
Top
Guidelines
For Eligibility, Guidelines and Performance Measurement please refer to the Proof of Principle: Phase I (2009-2010) funding opportunity.
Top
Performance Measurement
For Eligibility, Guidelines and Performance Measurement please refer to the Proof of Principle: Phase I (2009-2010) funding opportunity.
Top
Review Process and Evaluation
CIHR Research Priority Areas:
Relevance Review:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the Objectives section.
Prior to peer review, CIHR and the partner organizations will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application. This information will be used to review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.
Funding Decision:
Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) (unless otherwise specified) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted.
These applications will be funded from the top down in order of ranking as far as budgets will allow.
Applications that receive a rating below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
For Peer Review and Evaluation Criteria please refer to the Proof of Principal: Phase 1: 2009-2010 funding opportunity.
Top
How to Apply
- The application process is comprised of one stage: Application.
- Applications are submitted through the "201002-PPP" competition of the Proof of Principle: Phase I (2009-2010) funding opportunity.
- To complete your Application, follow the specific application guidelines and instructions which are fully described in the Proof of Principle: Phase I (2009-2010) "How to Apply" section.
- A step-by-step overview of CIHR's application processes can be found under Apply for Funding.
- Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.
Specific Requirements:
- Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
- To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
- You may request that your application be considered for up to three priority announcement research areas per application, in each Proof of Principle Phase I competition.
Top
Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Proof of Principle - Priority Announcement Program Delivery Team
Canadian Institutes of Health Research
Fax: 613-954-1800
Email: PA-AP@cihr-irsc.gc.ca
If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:
CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca
Top
Additional Information
Appendix 1: Contacts for questions about specific priority announcements and their research objectives
1. Cancer Early Detection, Imaging, or Translational Therapeutics
- For questions about this initiative and research objectives contact:
Benoît Lussier
Assistant Director
CIHR Institute of Cancer Research
Telephone: 514-398-4964
Fax: 514-398-8845
E-mail: benoit.lussier@mcgill.ca
2. Drug Development
- For questions about this initiative and research objectives contact:
Chaidwick Leneis
Senior KSE Specialist
Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-941-4437
Fax: 613-954-1800
Email: chaidwick.leneis@cihr-irsc.gc.ca
3. Regional Partnerships Program – New Brunswick
- For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne
Administrator
Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB, E3B 5G8
Telephone: 506 444-3222
Fax: 506 453-2958
Email: john.boyne@gnb.ca
- For questions regarding the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch,
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
CIHR
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
4. Regional Partnerships Program – Newfoundland and Labrador
- For additional information on eligibility criteria and funding details, please contact:
Office of Research and Graduate Studies
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL, A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
- For questions regarding the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch,
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
CIHR
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
Top
|
For technical problems, please contact us at 613-941-9080 or by e-mail at support@researchnet-recherchenet.ca, Monday-Friday from 8:30 a.m. to 4:30 p.m. Eastern Time.